GB2331763A9 - In vitro assay for modelling angiogenesis - Google Patents

In vitro assay for modelling angiogenesis

Info

Publication number
GB2331763A9
GB2331763A9 GB9821068A GB9821068A GB2331763A9 GB 2331763 A9 GB2331763 A9 GB 2331763A9 GB 9821068 A GB9821068 A GB 9821068A GB 9821068 A GB9821068 A GB 9821068A GB 2331763 A9 GB2331763 A9 GB 2331763A9
Authority
GB
United Kingdom
Prior art keywords
modelling
angiogenesis
vitro assay
vitro
assay
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
GB9821068A
Other versions
GB2331763A (en
GB9821068D0 (en
GB2331763B (en
Inventor
Eileen T Grant
Graham T Bell
Stephen Bloor
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biocure Ltd
Original Assignee
Biocure Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication of GB2331763A9 publication Critical patent/GB2331763A9/en
Priority claimed from GBGB9720987.8A external-priority patent/GB9720987D0/en
Application filed by Biocure Ltd filed Critical Biocure Ltd
Priority to GB9821068A priority Critical patent/GB2331763B/en
Publication of GB9821068D0 publication Critical patent/GB9821068D0/en
Publication of GB2331763A publication Critical patent/GB2331763A/en
Application granted granted Critical
Publication of GB2331763B publication Critical patent/GB2331763B/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5064—Endothelial cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5011—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing antineoplastic activity
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • G01N33/5029—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects on cell motility
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
GB9821068A 1997-10-01 1998-09-29 A Multicellular in vitro assay of angiogenesis Expired - Fee Related GB2331763B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB9821068A GB2331763B (en) 1997-10-01 1998-09-29 A Multicellular in vitro assay of angiogenesis

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9720987.8A GB9720987D0 (en) 1997-10-01 1997-10-01 A multicellular in vitro assay of angiogenesis
GB9821068A GB2331763B (en) 1997-10-01 1998-09-29 A Multicellular in vitro assay of angiogenesis

Publications (4)

Publication Number Publication Date
GB2331763A9 true GB2331763A9 (en)
GB9821068D0 GB9821068D0 (en) 1998-11-18
GB2331763A GB2331763A (en) 1999-06-02
GB2331763B GB2331763B (en) 2000-03-22

Family

ID=26312360

Family Applications (1)

Application Number Title Priority Date Filing Date
GB9821068A Expired - Fee Related GB2331763B (en) 1997-10-01 1998-09-29 A Multicellular in vitro assay of angiogenesis

Country Status (1)

Country Link
GB (1) GB2331763B (en)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPM425294A0 (en) * 1994-03-04 1994-03-31 Australian National University, The In-vitro angiogenesis assay

Also Published As

Publication number Publication date
GB2331763A (en) 1999-06-02
GB9821068D0 (en) 1998-11-18
GB2331763B (en) 2000-03-22

Similar Documents

Publication Publication Date Title
GB9719044D0 (en) Assay
EP0804727A4 (en) In vitro angiogenesis assay
GB9804385D0 (en) Scribing materials
GB9815224D0 (en) Assay
GB9704339D0 (en) Particulate material
GB9715522D0 (en) Assays
GB9610195D0 (en) Assay
GB9721240D0 (en) Assay
GB2331763A9 (en) In vitro assay for modelling angiogenesis
GB9727277D0 (en) Assay
GB9703717D0 (en) Illuminated article
GB9700071D0 (en) Rigid coloured articles
GB9717320D0 (en) Polyconductive material
GB2324094B (en) Improvements in perlite materials
GB9719428D0 (en) Assay
GB9614477D0 (en) Assay
AU1750095A (en) (in vitro) angiogenesis assay
TW355529U (en) Carrying structure for article
GB9707310D0 (en) Materials
GB9707040D0 (en) Assay
GB9726747D0 (en) Assay
GB9725231D0 (en) Assay
GB9724860D0 (en) Assay
GB9721868D0 (en) Assay
GB9719809D0 (en) Assay

Legal Events

Date Code Title Description
PCNP Patent ceased through non-payment of renewal fee

Effective date: 20140929